LEXICON PHARMACEUTICALS, INC.·4

Feb 14, 4:09 PM ET

Seth Kiernan 4

4 · LEXICON PHARMACEUTICALS, INC. · Filed Feb 14, 2022

Insider Transaction Report

Form 4
Period: 2022-02-10
Seth Kiernan
VP, Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-10+206,670206,670 total
    Exercise: $3.20Exp: 2032-02-10Common Stock (206,670 underlying)
  • Award

    Restricted Stock Units

    2022-02-10+68,89068,890 total
    Common Stock (68,890 underlying)
Footnotes (3)
  • [F1]Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT